iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of iTeos Therapeutics (NASDAQ:ITOS – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $46.00 target price on the stock. HC Wainwright also issued estimates for iTeos Therapeutics’ FY2029 earnings at $1.19 EPS. A number of other equities research analysts have […]
HC Wainwright restated their buy rating on shares of iTeos Therapeutics (NASDAQ:ITOS – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $46.00 target price on the stock. HC Wainwright also issued estimates for iTeos Therapeutics’ FY2029 earnings at $1.19 EPS. A number of other equities research analysts have […]
